230 related articles for article (PubMed ID: 19144998)
1. Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane.
Goldberg S; Harvey SJ; Cunningham J; Tryggvason K; Miner JH
Nephrol Dial Transplant; 2009 Jul; 24(7):2044-51. PubMed ID: 19144998
[TBL] [Abstract][Full Text] [Related]
2. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity.
Harvey SJ; Jarad G; Cunningham J; Rops AL; van der Vlag J; Berden JH; Moeller MJ; Holzman LB; Burgess RW; Miner JH
Am J Pathol; 2007 Jul; 171(1):139-52. PubMed ID: 17591961
[TBL] [Abstract][Full Text] [Related]
3. Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane.
Groffen AJ; Veerkamp JH; Monnens LA; van den Heuvel LP
Nephrol Dial Transplant; 1999 Sep; 14(9):2119-29. PubMed ID: 10489220
[TBL] [Abstract][Full Text] [Related]
4. Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane.
Groffen AJ; Ruegg MA; Dijkman H; van de Velden TJ; Buskens CA; van den Born J; Assmann KJ; Monnens LA; Veerkamp JH; van den Heuvel LP
J Histochem Cytochem; 1998 Jan; 46(1):19-27. PubMed ID: 9405491
[TBL] [Abstract][Full Text] [Related]
5. The reduction of heparan sulphate in the glomerular basement membrane does not augment urinary albumin excretion.
Aoki S; Saito-Hakoda A; Yoshikawa T; Shimizu K; Kisu K; Suzuki S; Takagi K; Mizumoto S; Yamada S; van Kuppevelt TH; Yokoyama A; Matsusaka T; Sato H; Ito S; Sugawara A
Nephrol Dial Transplant; 2018 Jan; 33(1):26-33. PubMed ID: 28992095
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate of perlecan is involved in glomerular filtration.
Morita H; Yoshimura A; Inui K; Ideura T; Watanabe H; Wang L; Soininen R; Tryggvason K
J Am Soc Nephrol; 2005 Jun; 16(6):1703-10. PubMed ID: 15872080
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the existence of multiple heparan sulfate proteoglycans in the human glomerular basement membrane and mesangial matrix.
Groffen AJ; Hop FW; Tryggvason K; Dijkman H; Assmann KJ; Veerkamp JH; Monnens LA; Van den Heuvel LP
Eur J Biochem; 1997 Jul; 247(1):175-82. PubMed ID: 9249024
[TBL] [Abstract][Full Text] [Related]
8. Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.
Borza DB
Matrix Biol; 2017 Jan; 57-58():299-310. PubMed ID: 27609404
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the glomerular charge barrier in the molecular era.
Harvey SJ; Miner JH
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):393-8. PubMed ID: 18660676
[TBL] [Abstract][Full Text] [Related]
10. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.
Raats CJ; Van Den Born J; Berden JH
Kidney Int; 2000 Feb; 57(2):385-400. PubMed ID: 10652015
[TBL] [Abstract][Full Text] [Related]
11. Organogenesis of the kidney glomerulus: focus on the glomerular basement membrane.
Miner JH
Organogenesis; 2011; 7(2):75-82. PubMed ID: 21519194
[TBL] [Abstract][Full Text] [Related]
12. Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma.
Kawahara R; Granato DC; Carnielli CM; Cervigne NK; Oliveria CE; Rivera C; Yokoo S; Fonseca FP; Lopes M; Santos-Silva AR; Graner E; Coletta RD; Paes Leme AF
PLoS One; 2014; 9(12):e115004. PubMed ID: 25506919
[TBL] [Abstract][Full Text] [Related]
13. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
[TBL] [Abstract][Full Text] [Related]
14. Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro.
van Det NF; van den Born J; Tamsma JT; Verhagen NA; van den Heuvel LP; Berden JH; Bruijn JA; Daha MR; van der Woude FJ
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):759-68. PubMed ID: 7537959
[TBL] [Abstract][Full Text] [Related]
15. Anti-heparan sulfate antibody and functional loss of glomerular heparan sulfate proteoglycans in lupus nephritis.
Kim HJ; Hong YH; Kim YJ; Kim HS; Park JW; Do JY; Kim KJ; Bae SW; Kim CW; Lee CK
Lupus; 2017 Jul; 26(8):815-824. PubMed ID: 28420046
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-specific deletion of NDST1, a key enzyme in the sulfation of heparan sulfate glycosaminoglycans, leads to abnormalities in podocyte organization in vivo.
Sugar T; Wassenhove-McCarthy DJ; Esko JD; van Kuppevelt TH; Holzman L; McCarthy KJ
Kidney Int; 2014 Feb; 85(2):307-18. PubMed ID: 23924956
[TBL] [Abstract][Full Text] [Related]
17. Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium.
Yard BA; Kahlert S; Engelleiter R; Resch S; Waldherr R; Groffen AJ; van den Heuvel LP; van der Born J; Berden JH; Kröger S; Hafner M; van der Woude FJ
Exp Nephrol; 2001; 9(3):214-22. PubMed ID: 11340306
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus.
Vernier RL; Steffes MW; Sisson-Ross S; Mauer SM
Kidney Int; 1992 Apr; 41(4):1070-80. PubMed ID: 1513088
[TBL] [Abstract][Full Text] [Related]
19. The glomerular basement membrane as a barrier to albumin.
Suh JH; Miner JH
Nat Rev Nephrol; 2013 Aug; 9(8):470-7. PubMed ID: 23774818
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
